Resources
Intelligence → Decision → Tool → ServiceArticles
- 01Experimental Design: CD16a 158V vs 158F Side-by-Side ComparisonArticles
- 02How to Select the Right CD16a (FcγRIIIa) Variant for FcγR Binding StudiesArticles
- 03CD47 / SIRPα Blocking Assay Design: Avoiding the Pitfalls That Invalidate Your DataArticles
- 04Choosing CD3 Protein Formats for T-Cell Engager DevelopmentArticles
- 05CHO vs HEK293 for Early BsAb ExpressionArticles
- 06How to Design a DLL3 × CD3 Functional Screening WorkflowArticles
- 07How to Validate Dual Binding for a Bispecific AntibodyArticles
- 08Human vs Cynomolgus Antigen SelectionArticles
- 09How to Design an FcRn SPR Assay for pH-Dependent Antibody Half-Life EvaluationArticles
- 10Step-by-Step: FcRn SPR Protocol with pH 6.0 / 7.4 Dual-Buffer SwitchArticles
- 11IL-15 for NK Cell Expansion: Concentrations, Combinations, and Common FailuresArticles
- 12PD-1 × VEGF-A Target Pair Landscape — What's Happening and Why It MattersArticles
- 13PD-L1 × VEGF-A Target Pair Landscape — Axis Validated, Format UnapprovedArticles
- 14DLL3 × CD3 Target Pair Landscape — The TCE Benchmark PairArticles
- 15EGFR × LGR5 Target Pair Landscape — An Emerging Pair With a Real Reagent GapArticles
- 16EGFR × MET Target Pair Landscape — Approved Reference, Multi-Generational PipelineArticles
- 17TIGIT / CD155 Matched Pair: Workflow and Optimization for BLI and SPRArticles
Hubs
- 01CD16a Hub — FcγRIIIa Variants & ADCC EvaluationHubs
- 02CD47 / SIRPα Hub — Macrophage Checkpoint Discovery ToolsHubs
- 03FcRn Hub — Antibody Half-Life & Fc EngineeringHubs
- 04IL-15 Hub — NK Expansion & Cell Therapy CytokinesHubs
- 05TIGIT / CD155 Hub — Matched Pair for Checkpoint ScreeningHubs